Add Yahoo as a preferred source to see more of our stories on Google. This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma ...

Many states are limiting access to HIV medications through ADAP programs as federal funding has remained largely flat despite rising costs. Luis Alvarez/Getty Images Several states are cutting or ...

The AIDS Healthcare Foundation is criticizing Gilead Sciences over the cost of HIV medications. Advocates warn that high drug ...

Trump administration officials are putting forward new data that shows U.S. federal anti-HIV/AIDS funding has continued to ...

HIV/AIDS activists heralded the approval of a new twice-yearly pre-exposure prophylaxis (PrEP) medication last year, but these celebrations were tempered by insurers’ reluctance to cover its ...

Thousands of low-income people living with HIV could be losing drug coverage as states impose limitations on HIV assistance programs amid constrained budgets — raising alarms over consistent access to ...

Researchers at the Manchester Institute of Biotechnology (MIB) have used engineering biology—an emerging technology that uses ...

At AMCP 2026, Kelsea Aragon, PharmD, discussed PrEP coverage, long-acting injectables, and payer strategies to improve HIV ...